dagogo jack sam (22 Ergebnisse)

Hardcover. Zustand: Very Good. No Jacket. May have limited writing in cover pages. Pages are unmarked. ~ ThriftBooks: Read More, Spend Less.

Zustand: New.

Zustand: New. In.

Zustand: Fair. 2. Fair-to-Good; Hardcover with Jacket; The front cover of this book is glossy and like new, but there is a heavy crease to the middle of the back cover; Unblemished textblock edges; The endpapers and all text pages are bright and unmarked; The binding is excellent with a straight spine; Book is like new except for the crease to the back cover; This book will be shipped in a sturdy cardboard box with foam padding; Medium Format (8.5" - 9.75" tall); Light green and white covers with title in green and red lettering; 2nd Edition; 2019, CRC Press; 470 pages; "Nutrition and Diabetes: Pathophysiology and Management," by Emmanuel C. Opara & Sam Dagogo-Jack.

Paperback. Zustand: Brand New. 2nd new edition. 470 pages. 10.00x7.01x1.34 inches. In Stock.

Kartoniert / Broschiert. Zustand: New. &Uumlber den AutorrnrnSam Dagogo-Jack, MD, DSc, is Professor of Medicine and Chief of the Division of Endocrinology, Diabetes and Metabolism at the University of Tennessee Health Science Center, Memphis, TN, where he holds the A. C. M.

Zustand: New. In.

Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.

Paperback. Zustand: Brand New. 1st edition. 137 pages. 8.07x5.24x0.32 inches. In Stock.

Hardcover. Zustand: Brand New. 1st edition. 287 pages. 10.25x7.25x1.00 inches. In Stock.

Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - Diabetes Guide adopts a novel 'non-textual' approach to thedissemination ofcomprehensive, up-to-date information onthe theory and practice of diabetology. This has beenachieved through the liberal use of tables, diagramsflowsheets, summaries and annotations in place of the usualprose and verbiage. As a result of such an economic use ofspace, vast amounts of knowledge on the definitionclassification, management complications and various otheraspects of diabetes have been condensed intoa surprisinglydigestible pocketbook. Emerging perspectives on geneticcounseling, the insulin gene and pancreatic transplantationare also incorporated. One outstanding feature of DiabetesGuide is the provision of succinct practical recommendationsfor the solution of problemsthat arise during the dailycare of patients with diabetes. The subjects covered underthese recommendations range from insulin infuser pumpproblems, care of foot ulcers, food exchanges, travel andacute illness, insulin allergy and desensitization protocoldiabetic emergencies,pregnancy, surgery, hypoglycaemiaetc. Such breadth of coverage has been achieved without theusual price of increased bulk through the unique'non-Textual' approach. Diabetes Guide is designed to be auser-friendly, ready reference of vade mecum for practicaltips and core information on various aspects of diabetes.; The Diabetes Guide adopts a novel, non-textual approach in order to present comprehensive, up-to-date information on the theory and practice of diabetology. Tables, diagrams, flowsheets, summaries and annotations take the place of the usual prose and verbiage. As a result, vast amounts of knowledge on the definition, classification, management, complications and various other aspects of diabetes have been condensed into a surprisingly digestible pocketbook. An outstanding feature of the Diabetes Guide is the provision of succinct, practical recommendations for solving problems that arise during the daily care of patients with diabetes. The subjects covered under these recommendations cover a wide range: insulin infuser pump problems, the care of foot ulcers, food exchanges, travel and acute illness, insulin allergy and desensitization protocol, diabetic emergencies, pregnancy, surgery, hypoglycaemia, etc. Emerging perspectives on genetic counseling, the insulin gene and pancreatic transplantation are also incorporated. Such breadth of coverage without the usual price of increased bulk has been made possible by the unique non-textual approach. The Diabetes Guide is truly a user-friendly, ready reference or vade mecum with practical tips and core information about diabetes.

Zustand: New. In.

Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - Twenty years after its discovery, recombinant human leptin has been approved by the Food and Drug Administration for the treatment of patients with lipodystrophy. Beginning with a synthesis of the vast body of work on its discovery, dissection of mechanisms, and effects in experimental models , the focus of this book shifts to a consideration of the regulation and role of leptin in humans. The emphasis on human-level data is a unique feature of this book. The results of numerous studies indicate that leptin is indeed a regulated human hormone.Leptin provides a detailed account of the myriad physiological, hormonal, metabolic, immunological, mitogenic and inflammatory modulators and targets of leptin in a single volume. Next follows a comprehensive presentation of the therapeutic trials of recombinant leptin in patients with congenital leptin deficiency, lipodystrophy, hypothalamic amenorrhea, and other emerging areas, including leptin supplementation in leptin-replete subjects, leptin substitution for insulin in diabetic models, and novel combination regimens of leptin and other biogenic peptides. Unanswered questions and future directions in leptin research are highlighted in the Foreword by Dr. Jeffrey Friedman and throughout the volume. Identifying such questions helps direct research that could deepen understanding of the complex regulation of leptin under physiological and pathological conditions, a critical prerequisite to its rational deployment in the treatment of human disorders.

Zustand: New. pp. 470.

Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - Adopting a truly global perspective and a practical approach to diabetes-including pathophysiology, genetics, regional peculiarities, management, prevention and best practices-this book is an excellent resource for clinicians and policy-makers working with patients in more austere settings. The global prevalence of diabetes is estimated to increase from 422 million in 2014 to 592 million in 2035. Sadly, low- and middle-economy countries are projected to experience the steepest increase, but even in developed economies, vulnerable demographic subgroups manifest disparities in diabetes prevalence, quality of care, and outcomes. This book extends coverage to those underserved and minority communities in the developed world. In a consistent chapter format, it discusses classification, pathophysiology, genomics, diagnosis, prevention and management of diabetes in economically challenged regions as well as underserved populations in affluent nations. Suggestions regarding future directions in the organization of diabetes care delivery, prevention and research priorities are also provided. The detailed identification of barriers to optimal care and the practical approach to the management and prevention of diabetes make Diabetes Mellitus in Developing Countries and Underserved Communities a valuable resource for clinicians, researchers and health policy leaders.

Hardcover. Zustand: Brand New. 294 pages. 10.10x7.40x1.00 inches. In Stock.

Taschenbuch. Zustand: Neu. Leptin | Regulation and Clinical Applications | Md Dagogo-Jack | Taschenbuch | xxiii | Englisch | 2016 | Springer | EAN 9783319354132 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.

Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - Twenty years after its discovery, recombinant human leptin has been approved by the Food and Drug Administration for the treatment of patients with lipodystrophy. Beginning with a synthesis of the vast body of work on its discovery, dissection of mechanisms, and effects in experimental models , the focus of this book shifts to a consideration of the regulation and role of leptin in humans. The emphasis on human-level data is a unique feature of this book. The results of numerous studies indicate that leptin is indeed a regulated human hormone.Leptin provides a detailed account of the myriad physiological, hormonal, metabolic, immunological, mitogenic and inflammatory modulators and targets of leptin in a single volume. Next follows a comprehensive presentation of the therapeutic trials of recombinant leptin in patients with congenital leptin deficiency, lipodystrophy, hypothalamic amenorrhea, and other emerging areas, including leptin supplementation in leptin-replete subjects, leptin substitution for insulin in diabetic models, and novel combination regimens of leptin and other biogenic peptides. Unanswered questions and future directions in leptin research are highlighted in the Foreword by Dr. Jeffrey Friedman and throughout the volume. Identifying such questions helps direct research that could deepen understanding of the complex regulation of leptin under physiological and pathological conditions, a critical prerequisite to its rational deployment in the treatment of human disorders.

Zustand: Sehr gut. Zustand: Sehr gut | Seiten: 312 | Sprache: Englisch | Produktart: Bücher | Twenty years after its discovery, recombinant human leptin has been approved by the Food and Drug Administration for the treatment of patients with lipodystrophy. Beginning with a synthesis of the vast body of work on its discovery, dissection of mechanisms, and effects in experimental models , the focus of this book shifts to a consideration of the regulation and role of leptin in humans. The emphasis on human-level data is a unique feature of this book. The results of numerous studies indicate that leptin is indeed a regulated human hormone.Leptin provides a detailed account of the myriad physiological, hormonal, metabolic, immunological, mitogenic and inflammatory modulators and targets of leptin in a single volume. Next follows a comprehensive presentation of the therapeutic trials of recombinant leptin in patients with congenital leptin deficiency, lipodystrophy, hypothalamic amenorrhea, and other emerging areas, including leptin supplementation in leptin-replete subjects, leptin substitution for insulin in diabetic models, and novel combination regimens of leptin and other biogenic peptides. Unanswered questions and future directions in leptin research are highlighted in the Foreword by Dr. Jeffrey Friedman and throughout the volume. Identifying such questions helps direct research that could deepen understanding of the complex regulation of leptin under physiological and pathological conditions, a critical prerequisite to its rational deployment in the treatment of human disorders.

Paperback. Zustand: Brand New. reprint edition. 312 pages. 9.30x6.20x0.74 inches. In Stock.

Zustand: New. In.

Hardcover. Zustand: Brand New. 2nd edition. 452 pages. 10.50x7.50x1.25 inches. In Stock.